Risk of type 2 diabetes in patients with nonalcoholic fatty liver disease: Causal association or epiphenomenon?

被引:0
|
作者
Targher, G. [1 ]
Marchesini, G.
Byrne, C. D.
机构
[1] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Piazzale Stefani 1, I-37126 Verona, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2016 / 2016
页数:1
相关论文
共 50 条
  • [21] Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
    Pozzan, Roselee
    Pena, Ronaldo Gama
    Vergara Palma, Catia Cristina Silva Sousa
    Abi-Abib, Raquel De Carvalho
    Terra, Carlos
    Cobas, Roberta Arnoldi
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (04): : 452 - 458
  • [22] Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Zhou, Qiumei
    Wang, Yulong
    Wang, Jiajia
    Liu, Yating
    Qi, Dehui
    Yao, Wei
    Jiang, Hui
    Li, Tingting
    Huang, Kaiquan
    Zhang, Wancun
    Huo, Xingxing
    MEDICINE, 2021, 100 (10)
  • [23] Nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Cusi, Kenneth
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 141 - 149
  • [24] Comparing the Association of Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease With Type 1 vs Type 2 Diabetes Mellitus
    Ghai, Megan B.
    Rangan, Pooja
    Han, Ma Ai Thanda
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1149 - S1150
  • [25] Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
    Cho, Hyo Jung
    Hwang, Sunhyuk
    Park, Jong Ik
    Yang, Min Jae
    Hwang, Jae Chul
    Yoo, Byung Moo
    Lee, Kee Myung
    Shin, Sung Jae
    Lee, Kwang Jae
    Kim, Jin Hong
    Cheong, Jae Youn
    Cho, Sung Won
    Kim, Soon Sun
    GUT AND LIVER, 2019, 13 (04) : 440 - 449
  • [26] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
  • [27] Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Pennisi, G.
    Enea, M.
    Falco, V.
    Aithal, G. P.
    Palaniyappan, N.
    Yilmaz, Y.
    Boursier, J.
    Cassinotto, C.
    De Ledinghen, V.
    Chan, W. K.
    Mahadeva, S.
    Eddowes, P.
    Newsome, P.
    Karlas, T.
    Wiegand, J.
    Wong, V. Wai-Sun
    Schattenberg, J. M.
    Labenz, C.
    Kim, W.
    Lee, M. S.
    Lupsor-Platon, M.
    Cobbold, J. F. L.
    Fan, J.
    Shen, F.
    Staufer, K.
    Trauner, M.
    Stauber, R.
    Nakajima, A.
    Yoneda, M.
    Bugianesi, E.
    Younes, R.
    Gaia, S.
    Zheng, M.
    Camma, C.
    Anstee, Q. M.
    Mozes, F. E.
    Pavlides, M.
    Petta, S.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S12 - S13
  • [29] Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Moh, Myint Aung Moh
    Jung, Chan-Hee
    Lee, Bora
    Choi, Dughyun
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Mok, Ji-Oh
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02): : 186 - 195
  • [30] Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes and association with micro- and macrovascular complications
    Ciardullo, S.
    Muraca, E.
    Perra, S.
    Manzoni, G.
    Oltolini, A.
    Zerbini, F.
    Cannistraci, R.
    Bianconi, E.
    Gastaldelli, A.
    Lattuada, G.
    Perseghin, G.
    DIABETOLOGIA, 2019, 62 : S534 - S535